The first World Oncoproteomics Congress is to be held in south San Francisco on 27-28 April 2006 to discuss biomarkers, molecular diagnostics, and personalised therapies for cancer
Select Conferences announces the inaugural world congress dedicated to oncoproteomics.
This field has developed rapidly over recent years and now is a good time to assess its success to date together with future opportunities and challenges.
The agenda will include cancer biomarkers, molecular diagnostics for cancer, laser capture microdissection, protein biochips, changes in proteome in cancer, and personalised therapies for cancer.
Some world class keynote speakers already confirmed with more pending.
To date they include Jack Roth, University of Texas Anderson Cancer Center, Gordon Whiteley, director, Clinical Proteomics Reference Lab, KK Jain, president, Jain PharmaBiotech.
Select Conferences is a division of Select Biosciences, focused on organising specialist biomedical meetings.
Experts from both academia and commerce are invited to present timely information from current research through to commercial implementation of new technologies.
These events also provide a unique networking facility and the opportunity to reach a highly targeted scientific audience.
